Literature DB >> 30839240

Pipeline embolisation device with shield technology for the treatment of ruptured intracranial aneurysm.

Christopher R Pasarikovski1, Ghouth Waggass2, Jillian Cardinell2, Peter Howard3,4, Leodante da Costa2, Victor Xd Yang1,2,5.   

Abstract

Flow diverters have emerged as a safe and effective treatment option for patients with complex unruptured cerebral aneurysms. Their utilisation in patients with ruptured aneurysms poses significant challenges, most notably the need for periprocedural dual antiplatelet medication. We describe the use of the pipeline embolisation device with shield technology in an 88-year-old patient with a complex ruptured posterior communicating artery aneurysm not amenable to microsurgical clipping or coiling alone. The pipeline embolisation device with shield technology utilises a phosphorylcholine coating to decrease thrombotic risk. We describe our antithrombotic protocol and technique to decrease the risk of acute re-rupture. The case highlights the option of using a flow diversion device with antithrombotic coatings in patients with complex ruptured cerebral aneurysms not amenable to coiling or microsurgical clipping.

Entities:  

Keywords:  Pipeline embolisation device; flow diversion; shield; subarachnoid haemorrhage

Mesh:

Substances:

Year:  2019        PMID: 30839240      PMCID: PMC6512202          DOI: 10.1177/1971400919834692

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  14 in total

Review 1.  Flow-diverter devices in the treatment of intracranial aneurysms: A meta-analysis and systematic review.

Authors:  Xianli Lv; Hongchao Yang; Peng Liu; Youxiang Li
Journal:  Neuroradiol J       Date:  2016-02-02

Review 2.  Endovascular treatment of cerebral aneurysms using flow-diverter devices: A systematic review.

Authors:  Francesco Briganti; Giuseppe Leone; Mariano Marseglia; Giuseppe Mariniello; Ferdinando Caranci; Arturo Brunetti; Francesco Maiuri
Journal:  Neuroradiol J       Date:  2015-08-27

3.  First US experience with Pipeline Flex with Shield Technology using aspirin as antiplatelet monotherapy.

Authors:  Ricardo A Hanel; Pedro Aguilar-Salinas; Leonardo Bc Brasiliense; Eric Sauvageau
Journal:  BMJ Case Rep       Date:  2017-05-04

4.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.

Authors:  Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

5.  Immediate and midterm results following treatment of recently ruptured intracranial aneurysms with the Pipeline embolization device.

Authors:  W McAuliffe; J D Wenderoth
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-01       Impact factor: 3.825

6.  Geographic variation and regional trends in adoption of endovascular techniques for cerebral aneurysms.

Authors:  Gabriel A Smith; Phillip Dagostino; Mitchell G Maltenfort; Aaron S Dumont; John K Ratliff
Journal:  J Neurosurg       Date:  2011-02-11       Impact factor: 5.115

7.  Pipeline flow diversion of ruptured blister aneurysms of the supraclinoid carotid artery using a single-device strategy.

Authors:  Robert W Ryan; Amir S Khan; Rebecca Barco; Armen Choulakian
Journal:  Neurosurg Focus       Date:  2017-06       Impact factor: 4.047

8.  Use of aspirin as sole oral antiplatelet therapy in acute flow diversion for ruptured dissecting aneurysms.

Authors:  Albert Ho Yuen Chiu; Rajalakshmi Ramesh; Jason Wenderoth; Mark Davies; Andrew Cheung
Journal:  J Neurointerv Surg       Date:  2016-09-28       Impact factor: 5.836

9.  Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study.

Authors:  Mario Martínez-Galdámez; Saleh M Lamin; Konstantinos G Lagios; Thomas Liebig; Elisa F Ciceri; Rene Chapot; Luc Stockx; Swarupsinh Chavda; Christoph Kabbasch; Giuseppe Farago; Hannes Nordmeyer; Thierry Boulanger; Mariangela Piano; Edoardo P Boccardi
Journal:  J Neurointerv Surg       Date:  2017-02-20       Impact factor: 5.836

10.  Analysis of neointima development in flow diverters using optical coherence tomography imaging.

Authors:  Yoshikazu Matsuda; Joonho Chung; Demetrius K Lopes
Journal:  J Neurointerv Surg       Date:  2017-06-07       Impact factor: 5.836

View more
  6 in total

1.  Pipeline Flex embolisation device with Shield Technology for the treatment of patients with intracranial aneurysms: periprocedural and 6 month outcomes.

Authors:  James Yeomans; Lilian Sandu; Anand Sastry
Journal:  Neuroradiol J       Date:  2020-10-22

2.  Delayed rupture of intracranial aneurysms after placement of intra-luminal flow diverter.

Authors:  Kun Hou; Guichen Li; Xianli Lv; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Neuroradiol J       Date:  2020-08-27

Review 3.  An international bibliometric study of scientific articles on intracranial aneurysms.

Authors:  Murat Kiraz; Emre Demir; Ömer Özdemir
Journal:  Neuroradiol J       Date:  2021-04-29

4.  Transient third cranial nerve palsy after pipeline shield treatment of a ruptured anterior cerebral artery dissecting aneurysm: Case report.

Authors:  David Vergara-Garcia; Juan Felipe Abaunza-Camacho; Mariana Agudelo-Arrieta; William Mauricio Riveros; Alberto Caballero
Journal:  Surg Neurol Int       Date:  2021-09-30

Review 5.  Biomimetic materials based on zwitterionic polymers toward human-friendly medical devices.

Authors:  Kazuhiko Ishihara
Journal:  Sci Technol Adv Mater       Date:  2022-09-13       Impact factor: 7.821

6.  Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology.

Authors:  Robert M Starke; John Thompson; Ariana Pagani; Animesh Choubey; John M Wainwright; Michael F Wolf; Reza Jahanbekam; Gaurav Girdhar
Journal:  J Neurointerv Surg       Date:  2020-06-02       Impact factor: 5.836

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.